DE60122141D1 - Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten - Google Patents

Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten

Info

Publication number
DE60122141D1
DE60122141D1 DE60122141T DE60122141T DE60122141D1 DE 60122141 D1 DE60122141 D1 DE 60122141D1 DE 60122141 T DE60122141 T DE 60122141T DE 60122141 T DE60122141 T DE 60122141T DE 60122141 D1 DE60122141 D1 DE 60122141D1
Authority
DE
Germany
Prior art keywords
transferase
screening
cymetics
medicaments
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60122141T
Other languages
English (en)
Other versions
DE60122141T2 (de
Inventor
Sunita Maria Desousa
Suresh Solapure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60122141D1 publication Critical patent/DE60122141D1/de
Application granted granted Critical
Publication of DE60122141T2 publication Critical patent/DE60122141T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245—Escherichia (G)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE60122141T 2000-06-08 2001-06-05 Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten Expired - Fee Related DE60122141T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN439MA2000 2000-06-08
INMA043900 2000-06-08
PCT/SE2001/001271 WO2001094622A1 (en) 2000-06-08 2001-06-05 Assay for detection of transferase enzyme activity in drug screening

Publications (2)

Publication Number Publication Date
DE60122141D1 true DE60122141D1 (de) 2006-09-21
DE60122141T2 DE60122141T2 (de) 2007-06-28

Family

ID=11097174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122141T Expired - Fee Related DE60122141T2 (de) 2000-06-08 2001-06-05 Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten

Country Status (10)

Country Link
US (4) US20030143635A1 (de)
EP (2) EP1292702A1 (de)
JP (2) JP2003535598A (de)
AT (1) ATE335841T1 (de)
AU (2) AU2001264482A1 (de)
CA (2) CA2407718A1 (de)
DE (1) DE60122141T2 (de)
ES (1) ES2269413T3 (de)
WO (2) WO2001094622A1 (de)
ZA (2) ZA200208624B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2370469A1 (en) * 1999-04-22 2000-11-02 Astrazeneca Ab Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
ATE335841T1 (de) * 2000-06-08 2006-09-15 Astrazeneca Ab Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten
SE0104101D0 (sv) * 2001-12-05 2001-12-05 Astrazeneca Ab New assay
SE0104102D0 (sv) 2001-12-05 2001-12-05 Astrazeneca Ab New assay
WO2004072607A2 (en) * 2003-02-05 2004-08-26 Merck & Co. Inc. High speed assay for glycosyl transferases
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US9902985B2 (en) 2012-04-06 2018-02-27 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
SE9404072D0 (sv) * 1994-11-24 1994-11-24 Astra Ab Novel polypeptides
US5861318A (en) * 1994-11-16 1999-01-19 Pharmacia & Upjohn Company Scintillation proximity assay for N-acetylgalactosaminyltransferase activity
US6153381A (en) * 1997-08-28 2000-11-28 Millennium Pharmaceuticals, Inc. Screening for antibiotics
AU2574199A (en) * 1998-02-02 1999-08-16 Princeton University Substrate analogs for murg, methods of making same and assays using same
EP1076719A1 (de) * 1998-05-15 2001-02-21 AstraZeneca AB Ein scintillationsannäherungsversuchsaufbau zur bestimmung von peptidoglykansynthese
US20010049117A1 (en) * 1998-08-20 2001-12-06 Helena R. Axelrod Analogs of udp-murnac peptides, assays, kits and related methods of their use
ATE335841T1 (de) * 2000-06-08 2006-09-15 Astrazeneca Ab Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten

Also Published As

Publication number Publication date
EP1292701A1 (de) 2003-03-19
JP2003535598A (ja) 2003-12-02
WO2001094623A1 (en) 2001-12-13
US20060228766A1 (en) 2006-10-12
WO2001094622A1 (en) 2001-12-13
US20030108969A1 (en) 2003-06-12
JP2003535597A (ja) 2003-12-02
AU2001264483A1 (en) 2001-12-17
ZA200208625B (en) 2003-08-04
DE60122141T2 (de) 2007-06-28
ES2269413T3 (es) 2007-04-01
ZA200208624B (en) 2003-08-04
ATE335841T1 (de) 2006-09-15
CA2407718A1 (en) 2001-12-13
US20030143635A1 (en) 2003-07-31
EP1292701B1 (de) 2006-08-09
US20060172361A1 (en) 2006-08-03
EP1292702A1 (de) 2003-03-19
CA2407934A1 (en) 2001-12-13
AU2001264482A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE60009575D1 (de) Nachweis von bakterien und bakteriophagen mit immobilisierten enzymsubstraten
DE60122141D1 (de) Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten
AU2003241311A1 (en) Simple catalytic dna biosensors for ions based on color changes
ATE271130T1 (de) Veränderte proteinkinasen, die modifizierte nukleotidtriphosphat substrate verwenden können
HK1054980A1 (zh) 利用肝臟干細胞進行毒性分型
HUP0200945A3 (en) Surrogate cell-based system and method for assaying the activity of hapatitis c virus ns3 protease
AU5143099A (en) Protein fragment complementation assays for the detection of biological or drug interactions
WO2003008635A3 (en) η-SECRETASE IN VITRO SCREENING ASSAY
SE0104102D0 (sv) New assay
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
DE60107428D1 (de) Nachweis und/oder unterscheidung der bakterien der gattung vibrio
DE60217079D1 (de) Nachweis und quantifizierung von cripto-1
DE60236996D1 (de) Kulturmedium zum nachweis von bakterien der gattung listeria
DE60109581D1 (de) Verfahren zur evaluierung von inplantierbaren materialien
WO2004043991A3 (en) Assay for tissue factor and factor viia
ATE460671T1 (de) Identifikation von arzneimittel gegen mykobakterien
ATE208504T1 (de) Komplex-gebundene hemmstoffe aktivierbarer stoffwechselenzyme als molekulare marker zur diagnostik und therapieüberwachung
EP1874953B8 (de) Verfahren zur bestimmung von phosphoryltransferase-aktivität unter verwendung von adenosin-5'-triphosphat (atp)-gamma-s
SE0104101D0 (sv) New assay
ATE368128T1 (de) Assays für c-mannosyltransferase
ATE314489T1 (de) Detektion von amplifizierten genprodukten zur gendetektion und reagenzkit
DE60139889D1 (de) Mutierte bcl-2 proteine und verwendung davon
ATE386142T1 (de) Fluoreszenz-basierte assays von dns-primasen
FI20002410A (fi) Menetelmä PCR-monistustuotteiden osoittamista ja tunnistamista varten ja nukleiinikoettimet eräille sienille sekä bakteereille

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee